fda approves semaglutide π The has approved (Ozempic) to reduce the risk of worsening kidney disease, kidney failure, and cardiovascular death in adults with type 2 diabetes (T2D) and chronic kidney disease (CKD) Ozempic Approval for Reducing Kidney
Description
Glucose-dependent means the effect is more closely tied to blood glucose levels than a fixed insulin push
This monitoring schedule should be maintained for patients starting semaglutide
Semaglutide produces significant weight loss, but its not a miracle cure
Kauh, C
The normal metabolism of BA plays a crucial role in maintaining the balance of intestinal flora
Longer term For longer protocols, review metabolic and kidney trends every 3-6 months with a clinician
